The timing of physical activity could affect the risk for CVD, according to study findings published in the European Journal of Preventive Cardiology.
Using data collected from February 2013 to December 2015 in the UK Biobank, the researchers identified several “chrono-activity” (daily physical activity timing) subgroups of 86,657 participants (mean age, 62 years; 58% women).
“Physical activity remains one of the most distinct cornerstones in CVD prevention. The present study adds to the previous evidence that timing of physical activity is an additional independent
The Liver Meeting 2022 delivered the latest research and developments on a variety of topics, including acute hepatitis in children, treatment for hepatitis-related cirrhosis and liver disease mortality during the COVID-19 pandemic.
Here are the top stories from this year’s meeting:
Although adenovirus infection has been widely implicated in an outbreak of acute, severe hepatitis in children, data presented found no “singular definitive etiology” for these cases.
“Beginning in October 2021, there were multiple clusters identified across the world of young children having
Abanza Tecnomed has announced FDA 510(k) clearance of its WasherCap, an implantable soft-tissue graft fixation system for patients undergoing ACL reconstruction, according to a company press release.
WasherCap is designed to offer surgeons a strong fixation device regardless of patients' bone quality for ACL reconstruction, according to the release.
“The FDA clearance of WasherCap is exciting because it offers surgeons a highly reliable solution for soft-tissue graft fixation, especially valuable for young, adults and female patients, as well as revision procedures,” Juan Abascal,
Non-U.S. citizen international medical graduates likely face considerable bias during the hematology/oncology fellowship recruitment process, according to study results.
More than one-third of physicians practicing hematology/oncology in the United States are international medical graduates.
“There is very little data about perceptions regarding them and how they do in the fellowship recruitment process,” Ayesha Butt, MBBS, postdoctoral research associate in hematology at Yale Cancer Center, told Healio.
Butt and colleagues conducted a national survey of U.S. hematology and medical
PHILADELPHIA — Researchers have identified “dozens” of new causal genes and pathways responsible for disease activity in patients with gout, according to a presenter at ACR Convergence 2022.
“We have had urate genome-wide association studies revealing over 200 loci controlling serum urate levels and these are dominated by molecular control of renal and gut excretion of urate,” Tony Merriman, PhD, of the University of Alabama at Birmingham, told attendees. “Our hypothesis goes that there are unidentified genes in the human genome that are involved in